[The treatment of intestinal helminthiasis with mebendazole. 294 treated patients].
294 patients with slight intestinal helminthic infections have been treated with mebendazole, a broad-spectrum antihelminthic of high effectiveness and remarkably low toxicity. The high cure rates (91-95%) obtained in cases of trichuriasis, ascariasis and ankylostomiasis are in agreement with the results as published by other investigators. For helminthiases, the present patient sample was too limited to permit accurate evaluation. Nevertheless, mebendazole may be considered the drug of choice for treatment of trichuriasis in particular and for intestinal helminthic polyparasitism in general.
D001196:Ascariasis / Q000188:drug therapy; D001562:Benzimidazoles / Q000627:therapeutic use*; D004802:Eosinophilia / Q000209:etiology; D005243:Feces / Q000469:parasitology; D006373:Helminthiasis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy*; D008463:Mebendazole / Q000627:therapeutic use*; D014257:Trichuriasis / Q000188:drug therapy
D001562:Benzimidazoles; D008463:Mebendazole
Le traitement des helminthiases intestinales au mébendazole a propos de 294 patients traités